Christian Schulze: Time to Say Good-Bye to The “Obesity Paradox”?
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn:
”Microvascular dysfunction is a remaining diagnostic and therapeutic challenge in ACS.
We show that an increased BMI has been associated with microvascular dysfunction after NSTEMI.
BMI above 25.6 kg/m² is an independent predictors of microvascular dysfunction.
Time to say good-bye to the “obesity paradox”?
Congrats to the TATORT-NSTEMI investigators!”
Read the full article here.
Article: Overweight predisposes to microvascular obstruction: insights from the TATORT-NSTEMI trial
Authors: Felix Troger, Ingo Eitel, Roza Saraei, Thomas Stiermaier, Michael Böhm, Bernward Lauer, P Christian Schulze, Tobias Geisler, Leonhard Bruch, Norbert Klein, Uwe Zeymer, Agnes Mayr, Maria Buske, Steffen Desch, Holger Thiele, Hans-Josef Feistritzer
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis